Progyny Inc (PGNY)
32.60
+0.24
(+0.74%)
USD |
NASDAQ |
Apr 24, 16:00
32.60
0.00 (0.00%)
After-Hours: 20:00
Progyny SG&A Expense (Quarterly): 43.09M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 43.09M |
September 30, 2023 | 44.44M |
June 30, 2023 | 45.46M |
March 31, 2023 | 43.63M |
December 31, 2022 | 41.19M |
September 30, 2022 | 34.74M |
June 30, 2022 | 35.05M |
March 31, 2022 | 33.01M |
December 31, 2021 | 25.30M |
September 30, 2021 | 19.43M |
June 30, 2021 | 17.96M |
Date | Value |
---|---|
March 31, 2021 | 17.10M |
December 31, 2020 | 19.50M |
September 30, 2020 | 16.01M |
June 30, 2020 | 13.03M |
March 31, 2020 | 13.17M |
December 31, 2019 | 10.62M |
September 30, 2019 | 9.251M |
June 30, 2019 | 9.098M |
March 31, 2019 | 6.854M |
December 31, 2018 | 6.118M |
September 30, 2018 | 5.634M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
9.098M
Minimum
Jun 2019
45.46M
Maximum
Jun 2023
25.85M
Average
19.50M
Median
Dec 2020
SG&A Expense (Quarterly) Benchmarks
Delcath Systems Inc | 6.963M |
Star Equity Holdings Inc | 3.211M |
Exact Sciences Corp | 411.03M |
Illumina Inc | 485.00M |
CytoSorbents Corp | 10.56M |